RODNEY BEATY: Open Payments
NPI 1497747596 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,417 in 71 payments from 22 companies in 2025. Trend: 2023 $4,149 · 2024 $4,172 · 2025 $1,417
Food & beverage: $1,417
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 19 | $225 |
| GlaxoSmithKline, LLC. | 8 | $157 |
| Daiichi Sankyo Inc. | 8 | $136 |
| Biosense Webster, Inc. | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 6 | $103 |
| Exelixis Inc. | 3 | $92 |
| PFIZER INC. | 3 | $80 |
| ABBVIE INC. | 4 | $76 |
| SOBI, INC | 3 | $73 |
| PharmaEssentia USA Corporation | 2 | $64 |
Products named: Vyloy, QDOT MICRO, PLUVICTO, CABOMETYX, OJJAARA, IBRANCE, JEMPERLI, BESREMI.
Industry payments across CA — which companies pay providers there.
